What AI says about Risdiplam (Evrysdi)

Evrysdi (risdiplam) is an approved treatment for spinal muscular atrophy (SMA) in patients from birth, administered daily at home as a liquid by mouth or feeding tube. It works as an SMN2 mRNA splicing modifier to increase and sustain SMN protein production in the central nervous system and peripheral tissues.